Nicotine Lozenges vs Nicotine Patches for focus
Short answer: For focus, users rate them about the same: 90% report improvement with Nicotine Lozenges (10 reports) and 94% with Nicotine Patches (17 reports).
Nicotine Lozenges has 3 meta-analyses and 18 randomized trials on PubMed; Nicotine Patches has 33 and 236.
Based on 26 reports about Nicotine Lozenges and 43 about Nicotine Patches. Not medical advice.
| Nicotine Lozenges Substance | Nicotine Patches Substance | |
|---|---|---|
| Users say it helped | 33%helped15 reports · few reports | 70%helped30 reports · medium confidence |
| Verdict | Mixed | Mostly positive |
| Research | AResearch: Strong | AResearch: Strong |
| Meta-analyses / RCTs | 3 / 18 | 33 / 236 |
| Mainly used for | ||
| Focus % reporting improvement | 90% (10) | 94% (17) |
| Mood % reporting improvement | — | 80% (5) |
| Common side effects | addiction, nausea, throat pain, teeth damage | dependence, tingling, fatigue, overwhelming |
| Typical dose reported | 2-20 mg / daily | 7-14 mg / 4 days/week, 8 hours per day |
There is evidence that preoperative smoking interventions providing behavioural support and offering NRT increase short-term smoking cessation and may reduce postoperative morbidity. One trial of varenicline begun shortly before surgery has shown a benefit on long-term cessation but did not detect an effect on early abstinence or on postoperative complications. The optimal preoperative intervention intensity remains unknown. Based on indirect comparisons and evidence from two small trials, interventions that begin four to eight weeks before surgery, include weekly counselling and use NRT are m
Cochrane Database Syst Rev, 2014 ↗“I'm hooked on nicotine lozenges... They help me both not smoke as well as feel mentally sharper.”
At present, it is impossible to draw any firm conclusions about the effectiveness, or a lack of it, of smoking cessation competitions. This is due to a lack of well-designed comparative studies. Smoking cessation competitions have not been shown to enhance long-term cessation rates. The limited evidence suggesting that population-based Quit & Win contests at local and regional level might deliver quit rates above baseline community rates has not been tested adequately using rigorous study designs. It is also unclear whether the value or frequency of possible cash reward schedules influence the
Cochrane Database Syst Rev, 2019 ↗“Patches don't hit me with a high, but I feel more focused, energized, and positive with them as opposed to no nicotine.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate